Skip to main content
Log in

Clinical effects of remimazolam alone or in combination with dexmedetomidine in patients receiving bronchoscopy and influences on postoperative cognitive function: a randomized-controlled trial

  • Research Article
  • Published:
International Journal of Clinical Pharmacy Aims and scope Submit manuscript

Abstract

Background

Remimazolam and dexmedetomidine are commonly used as sedatives. However, the effects and safety of remimazolam alone or in combination with dexmedetomidine have not been investigated.

Aim

We sought to investigate the clinical effects of remimazolam alone or in combination with dexmedetomidine in bronchoscopy, and their influence on cognitive function.

Method

Ninety eligible patients who underwent bronchoscopy under intravenous anesthesia were randomly divided into three groups: propofol control, remimazolam, and remimazolam plus dexmedetomidine. The primary outcome was the incidence of perioperative hypoxemia. Secondary outcomes included induction and maintenance doses of remimazolam, hemodynamic variables, scores for modified Observer's Assessment of Alertness/Sedation (MOAA/S), coughing, limb movement, incidence of adverse events, patient satisfaction, bronchoscopist satisfaction, incidence of post-operative cognitive dysfunction (POCD), time to loss of consciousness (LoC), and time to awake.

Results

The incidence of hypoxemia, hypotension, and bronchoscopist satisfaction score were significantly decreased, and time to LoC and time to awake were markedly longer in the remimazolam and remimazolam plus dexmedetomidine groups than in the propofol control group (p < 0.05). The remimazolam group had significantly decreased induction and maintenance doses of remimazolam and a shorter time to LoC than the remimazolam plus dexmedetomidine group (p < 0.05). Scores for coughing, limb movement, MOAA/S, and post-operative patient satisfaction were comparable among the three groups. POCD was not induced in any of the groups.

Conclusion

Remimazolam is safe and effective for painless bronchoscopy, with a low incidence of adverse reactions, and exhibits a good synergistic effect with dexmedetomidine.

Trial Registration

This trial protocol had been registered on Chinese Clinical Trial Registry (ChiCTR2000041435, date: 2020 12 26

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Criner GJ, Eberhardt R, Fernandez-Bussy S, et al. Interventional Bronchoscopy. Am J Respir Crit Care Med. 2020;202(1):29–50.

    Article  PubMed  Google Scholar 

  2. Nelson ME. Moderate sedation changes for bronchoscopy in 2017. Chest. 2017;152(4):893–7.

    Article  PubMed  Google Scholar 

  3. McCambridge AJ, Boesch RP, Mullon JJ. Sedation in bronchoscopy: a review. Clin Chest Med. 2018;39(1):65–77.

    Article  PubMed  Google Scholar 

  4. Wang Z, Hu Z, Dai T. The comparison of propofol and midazolam for bronchoscopy: a meta-analysis of randomized controlled studies. Medicine (Baltimore). 2018;97(36):1–5.

    Article  Google Scholar 

  5. Ho C, Hayes D Jr, Khosravi M, et al. Sedation with propofol for bronchoscopy in cystic fibrosis lung transplant recipients. Lung. 2018;196(4):435–9.

    Article  CAS  PubMed  Google Scholar 

  6. Ferguson I, Bell A, Treston G, et al. Propofol or ketofol for procedural sedation and analgesia in emergency medicine-the POKER study: a randomized double-blind clinical trial. Ann Emerg Med. 2016;68(5):574-82.e1.

    Article  PubMed  Google Scholar 

  7. Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol. 2020;33(4):506–11.

    Article  PubMed  Google Scholar 

  8. Doi M, Hirata N, Suzuki T, et al. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34(4):491–501.

    Article  PubMed  Google Scholar 

  9. Rex DK, Bhandari R, Desta T, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88(3):427-37.e6.

    Article  PubMed  Google Scholar 

  10. Pastis NJ, Yarmus LB, Schippers F, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155(1):137–46.

    Article  PubMed  Google Scholar 

  11. Liu X, Lin S, Zhong Y, et al. Remimazolam protects against lps-induced endotoxicity improving survival of endotoxemia mice. Front Pharmacol. 2021;12: 739603.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Chadha M, Kulshrestha M, Biyani A. Anaesthesia for bronchoscopy. Indian J Anaesth. 2015;59(9):565–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dang X, Hu W, Yang Z, et al. Dexmedetomidine plus sufentanil for pediatric flexible bronchoscopy: a retrospective clinical trial. Oncotarget. 2017;8(25):41256–64.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Wu SH, Lu DV, Hsu CD, et al. The effectiveness of low-dose dexmedetomidine infusion in sedative flexible bronchoscopy: a retrospective analysis. Medicina (Kaunas). 2020;56(4):1–7.

    Google Scholar 

  15. Sharma J, Purohit S, Bhatia S, et al. Awake orotracheal fibre-optic intubation: comparison of two different doses of dexmedetomidine on intubation conditions in patients undergoing cervical spine surgery. Indian J Anaesth. 2017;61(10):811–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Gan J, Tu Q, Miao S, et al. Effects of oxycodone applied for patient-controlled analgesia on postoperative cognitive function in elderly patients undergoing total hip arthroplasty: a randomized controlled clinical trial. Aging Clin Exp Res. 2020;32(2):329–37.

    Article  PubMed  Google Scholar 

  17. Gao Y, Kang K, Liu H, et al. Effect of dexmedetomidine and midazolam for flexible fiberoptic bronchoscopy in intensive care unit patients: a retrospective study. Medicine (Baltimore). 2017;96(25):1–6.

    Article  Google Scholar 

  18. Xue FS, He N, Liao X, et al. Clinical assessment of awake endotracheal intubation using the lightwand technique alone in patients with difficult airways. Chin Med J (Engl). 2009;122(4):408–15.

    PubMed  Google Scholar 

  19. Wahidi MM, Jain P, Jantz M, et al. American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients. Chest. 2011;140(5):1342–50.

    Article  CAS  PubMed  Google Scholar 

  20. Noda N, Hara M, Ise S, et al. Comfort and safety of bronchoscopy performed under sedation and local anesthesia in elderly patients. Medicine (Baltimore). 2020;99(43): e22561.

    Article  PubMed  Google Scholar 

  21. Maurel V, Legrand M, Bourgeois E, et al. Sedation with remifentanil or propofol for flexible bronchoscopy: a randomised controlled trial. Eur J Anaesthesiol. 2020;37(4):333–4.

    Article  PubMed  Google Scholar 

  22. Doi M, Morita K, Takeda J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34(4):543–53.

    Article  PubMed  Google Scholar 

  23. Gralnek IM, Bisschops R, Matharoo M, et al. Guidance for the implementation of a safety checklist for gastrointestinal endoscopic procedures: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology and Endoscopy Nurses and Associates (ESGENA) Position Statement. Endoscopy. 2022;54(2):206–10.

    Article  PubMed  Google Scholar 

  24. Lee JG, Yoo KS, Byun YJ. Continuous infusion versus intermittent bolus injection of propofol during endoscopic retrograde cholangiopancreatography. Korean J Intern Med. 2020;35(6):1338–45.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Eisenried A, Schüttler J, Lerch M, et al. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part II. Pharmacodynam Electroencephalogram Effects Anesthesiol. 2020;132(4):652–66.

    CAS  Google Scholar 

  26. Schüttler J, Eisenried A, Lerch M, et al. Pharmacokinetics and pharmacodynamics of Remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: Part I. Pharmacokinet Clin Pharmacodynam Anesthesiol. 2020;132(4):636–51.

    Google Scholar 

  27. Zha B, Wu Z, Xie P, et al. Supraglottic jet oxygenation and ventilation reduces desaturation during bronchoscopy under moderate to deep sedation with propofol and remifentanil: a randomised controlled clinical trial. Eur J Anaesthesiol. 2021;38(3):294–301.

    Article  CAS  PubMed  Google Scholar 

  28. Zhang H, Fang B, Zhou W. The efficacy of dexmedetomidine-remifentanil versus dexmedetomidine-propofol in children undergoing flexible bronchoscopy: a retrospective trial. Medicine (Baltimore). 2017;96(1):1–6.

    Article  Google Scholar 

  29. Paul M, Rastogi A, Chatterje A, et al. Comparative evaluation of propofol and combination of propofol-dexmedetomidine in adjunct with topical airway anesthesia for rigid bronchoscopy: a randomized double-blinded prospective study. Ann Card Anaesth. 2021;24(1):49–55.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Abulebda K, Abu-Sultaneh S, Ahmed SS, et al. Intensivist-based deep sedation using propofol for pediatric outpatient flexible bronchoscopy. World J Crit Care Med. 2017;6(4):179–84.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Sottas CE, Anderson BJ. Dexmedetomidine: the new all-in-one drug in paediatric anaesthesia? Curr Opin Anaesthesiol. 2017;30(4):441–51.

    Article  CAS  PubMed  Google Scholar 

  32. Li H, Zhang N, Zhang K, et al. Observation of the clinical efficacy of dexmedetomidine in flexible bronchoscopy under general anesthesia: clinical case experience exchange. J Int Med Res. 2019;47(12):6215–22.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Weerink MAS, Struys M, Hannivoort LN, et al. Clinical pharmacokinetics and pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893–913.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019;72(4):323–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zhang J, Liu G, Zhang F, et al. Analysis of postoperative cognitive dysfunction and influencing factors of dexmedetomidine anesthesia in elderly patients with colorectal cancer. Oncol Lett. 2019;18(3):3058–64.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

None.

Funding

This study was supported by Scientific Research Foundation of comfort medicine of Shandong Province Medical Association in 2020 (No. YXH2020ZX023).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shengqiang Yang.

Ethics declarations

Conflicts of interest

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, S., Wang, T., Cao, L. et al. Clinical effects of remimazolam alone or in combination with dexmedetomidine in patients receiving bronchoscopy and influences on postoperative cognitive function: a randomized-controlled trial. Int J Clin Pharm 45, 137–145 (2023). https://doi.org/10.1007/s11096-022-01487-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-022-01487-4

Keywords

Navigation